Quantification of Axonal Damage in Traumatic Brain Injury

Abstract : Diffuse axonal injury is a primary feature of head trauma and is one of the most frequent causes of mortality and morbidity. Diffuse axonal injury is microscopic in nature and difficult or impossible to detect with imaging techniques. The objective of the present study was to determine whether axonal injury in head trauma patients could be quantified by measuring levels of CSF tau proteins. Tau proteins are structural microtubule binding proteins primarily localized in the axonal compartment of neurons. Monoclonal antibodies recognizing the form of tau found in the CSF of head trauma patients were developed by differential CSF hybridoma screening using CSF from head trauma and control patients. Clones positive for head trauma CSF tau proteins were used to characterize this form of tau and for ELISA development. Using the developed ELISA, CSF tau levels were elevated >1,000‐fold in head trauma patients (mean, 1,519 ng/ml of CSF) when compared with patients with multiple sclerosis (mean, 0.014 ng/ml of CSF ; p < 0.001), normal pressure hydrocephalus (nondetectable CSF tau), neurologic controls (mean, 0.031 ng/ml of CSF ; p < 0.001), or nonneurologic controls (nondetectable CSF tau ; p < 0.001). In head trauma, a relationship between clinical improvement and decreased CSF tau levels was observed. These data suggest that CSF tau levels may prove a clinically useful assay for quantifying the axonal injury associated with head trauma and monitoring efficacy of neuroprotective agents. Affinity purification of CSF tau from head trauma patients indicated a uniform cleavage of ~ 18 kDa from all six tau isoforms, reducing their apparent molecular sizes to 30‐50 kDa. These cleaved forms of CSF tau consisted of the interior portion of the tau sequence, including the microtubule binding domain, as judged by cyanogen bromide digestion. Consistent with these data, CSF cleaved tau bound taxolpolymerized microtubules, indicating a functionally intact microtubule binding domain. Furthermore, epitope mapping studies suggested that CSF cleaved tau proteins consist of the interior portion of the tau sequence with cleavage at both N and C terminals.

[1]  Douglas Galasko,et al.  The τ Protein in Human Cerebrospinal Fluid in Alzheimer's Disease Consists of Proteolytically Derived Fragments , 1997, Journal of neurochemistry.

[2]  I. Nishimoto,et al.  Apoptosis in neurodegenerative diseases. , 1997, Advances in pharmacology.

[3]  J. Kuret,et al.  The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology* , 1996, The Journal of Biological Chemistry.

[4]  G. E. Dean,et al.  Monoclonal antibody PHF‐9 recognizes phosphorylated serine 404 of tau protein and labels paired helical filaments , 1996, Journal of neuroscience research.

[5]  P. Davies,et al.  Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.

[6]  B. Rowlands,et al.  Neuron-specific enolase as an aid to outcome prediction in head injury. , 1996, British journal of neurosurgery.

[7]  J. Povlishock,et al.  Traumatically induced axonal damage: evidence for enduring changes in axolemmal permeability with associated cytoskeletal change. , 1996, Acta neurochirurgica. Supplement.

[8]  J. Trojanowski,et al.  Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease , 1995, Annals of neurology.

[9]  J. Povlishock,et al.  The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts. , 1995, Journal of neurotrauma.

[10]  L. Chang,et al.  Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease , 1995, Neurology.

[11]  R. Sobel.  The pathology of multiple sclerosis. , 1995, Neurologic clinics.

[12]  N. Hirokawa,et al.  Sorting mechanisms of Tau and MAP2 in neurons: Suppressed axonal transit of MAP2 and locally regulated microtubule binding , 1995, Neuron.

[13]  M. Goedert,et al.  Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404 , 1994, Journal of neuroscience research.

[14]  J. Albala,et al.  Localization of Specific Epitopes on Human Microtubule‐Associated Protein 2 , 1994, Journal of neurochemistry.

[15]  T. Gotow,et al.  Phosphorylation of neurofilament H subunit as related to arrangement of neurofilaments , 1994, Journal of neuroscience research.

[16]  L. Gentry,et al.  Imaging of closed head injury. , 1994, Radiology.

[17]  J. Cramer,et al.  Quality of life for people with epilepsy. , 1994, Neurologic clinics.

[18]  Jan Six,et al.  Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay , 1993 .

[19]  A. Baker,et al.  Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. , 1993, Journal of neurosurgery.

[20]  J. Barg,et al.  Subcellular localization of tau mRNA in differentiating neuronal cell culture: Implications for neuronal polarity , 1993, Neuron.

[21]  W. T. Moore,et al.  Application of synthetic phospho‐ and unphospho‐ peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease , 1993, Journal of neuroscience research.

[22]  E. Mandelkow,et al.  Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Lee,et al.  Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. , 1992, Journal of cell science.

[24]  K. Titani,et al.  Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments , 1992 .

[25]  C. W. Scott,et al.  Immunological characterization of the region of tau protein that is bound to Alzheimer paired helical filaments , 1992, Neurobiology of Aging.

[26]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[27]  A. Faden,et al.  Pharmacological strategies in CNS trauma. , 1992, Trends in pharmacological sciences.

[28]  A. Umemura,et al.  Serum neuron-specific enolase levels after subarachnoid hemorrhage. , 1991, Surgical neurology.

[29]  M N Bobrow,et al.  Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. , 1991, Journal of immunological methods.

[30]  D. Hovda,et al.  Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. , 1990, Journal of neurosurgery.

[31]  U. Ungerstedt,et al.  Changes in Cortical Extracellular Levels of Energy-Related Metabolites and Amino Acids following Concussive Brain Injury in Rats , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  T. Harris,et al.  Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. , 1989, Journal of immunological methods.

[33]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[34]  J. Adams,et al.  Diffuse axonal injury in head injury: Definition, diagnosis and grading , 1989, Histopathology.

[35]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[36]  A Hirano,et al.  INCREASED DIAMETER OF DEMYELINATED AXONS IN CHRONIC MULTIPLE SCLEROSIS OF THE SPINAL CORD , 1988, Neuropathology and applied neurobiology.

[37]  P. Davies,et al.  Alzheimer‐related neuronal protein A68: Specificity and distribution , 1987, Annals of neurology.

[38]  K S Kosik,et al.  MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  D. Selkoe,et al.  Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Dickson,et al.  A neuronal antigen in the brains of Alzheimer patients. , 1986, Science.

[41]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[42]  J. Nunez,et al.  Immunological characterization of microtubule‐associated proteins specific for the immature brain , 1985, FEBS letters.

[43]  P. Marangos,et al.  Severe head trauma and the changes of concentration of neuron-specific enolase in plasma and in cerebrospinal fluid. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[44]  J. Pujol,et al.  Neuron-specific enolase as a marker of neuronal lesions during various comas in man , 1982, Neurochemistry International.

[45]  J. Ulrich,et al.  Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants , 1982, Nature.

[46]  R. Vallee.  A taxol-dependent procedure for the isolation of microtubules and microtubule-associated proteins (MAPs) , 1982, The Journal of cell biology.

[47]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[48]  F. Goodwin,et al.  The existence and neurobiological significance of neuronal and glial forms of the glycolytic enzyme enolase. , 1979, Biological psychiatry.

[49]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.

[50]  M. Kirschner,et al.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.

[51]  B Jennett,et al.  Severe head injuries in three countries. , 1977, Journal of neurology, neurosurgery, and psychiatry.

[52]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[53]  D. Boorsma,et al.  A comparative study of horseradish peroxidase conjugates prepared with a one-step and a two-step method. , 1975, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[54]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[55]  S. Strich,et al.  SHEARING OF NERVE FIBRES AS A CAUSE OF BRAIN DAMAGE DUE TO HEAD INJURY: A Pathological Study of Twenty Cases , 1961 .